Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion

NCT05759078 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction, Acute

Interventions

DRUG: Ferinject
DRUG: Sodium Chloride 0.9% Inj

Sponsor

Wroclaw Medical University